|
Spdr Series Trust State Street Spd Put Option
(XBI)
|
10.4 |
$183M |
|
1.5M |
121.93 |
|
Apogee Therapeutics
(APGE)
|
5.3 |
$93M |
|
1.2M |
75.48 |
|
Insmed Com Par $.01
(INSM)
|
4.5 |
$78M |
|
450k |
174.04 |
|
Abivax Sa Sponsored Ads
(ABVX)
|
3.9 |
$68M |
|
505k |
134.85 |
|
Ishares Tr Ishares Biotech Call Option
(IBB)
|
3.8 |
$68M |
|
400k |
168.77 |
|
Ventyx Biosciences
(VTYX)
|
3.3 |
$59M |
|
6.5M |
9.03 |
|
Xenon Pharmaceuticals
(XENE)
|
3.2 |
$56M |
|
1.3M |
44.82 |
|
Praxis Precision Medicines I Com New
(PRAX)
|
3.1 |
$55M |
|
185k |
294.74 |
|
Cytokinetics Com New
(CYTK)
|
2.9 |
$51M |
|
800k |
63.54 |
|
Amgen
(AMGN)
|
2.7 |
$48M |
|
145k |
327.31 |
|
Spyre Therapeutics Com New
(SYRE)
|
2.7 |
$47M |
|
1.4M |
32.76 |
|
Wave Life Sciences SHS
(WVE)
|
2.6 |
$46M |
|
2.7M |
17.00 |
|
Teva Pharmaceutical Inds Sponsored Ads
(TEVA)
|
2.5 |
$44M |
|
1.4M |
31.21 |
|
Select Sector Spdr Tr State Street Hea Call Option
(XLV)
|
2.2 |
$39M |
|
250k |
154.80 |
|
Roivant Sciences SHS
(ROIV)
|
2.1 |
$37M |
|
1.7M |
21.70 |
|
Arcellx Common Stock
(ACLX)
|
1.9 |
$34M |
|
524k |
65.20 |
|
Nuvalent Inc-a
(NUVL)
|
1.8 |
$33M |
|
323k |
100.59 |
|
Lexeo Therapeutics
(LXEO)
|
1.8 |
$32M |
|
3.2M |
9.93 |
|
Alkermes SHS
(ALKS)
|
1.6 |
$28M |
|
1.0M |
27.98 |
|
Forte Biosciences Com New
(FBRX)
|
1.6 |
$28M |
|
1.0M |
27.27 |
|
Trevi Therapeutics
(TRVI)
|
1.5 |
$27M |
|
2.2M |
12.52 |
|
Mineralys Therapeutics
(MLYS)
|
1.5 |
$27M |
|
730k |
36.29 |
|
Bridgebio Pharma
(BBIO)
|
1.4 |
$25M |
|
320k |
76.49 |
|
Oruka Therapeutics
(ORKA)
|
1.4 |
$24M |
|
802k |
30.31 |
|
Terns Pharmaceuticals
(TERN)
|
1.3 |
$22M |
|
550k |
40.40 |
|
Anaptysbio Inc Common
(ANAB)
|
1.2 |
$22M |
|
445k |
48.48 |
|
Uniqure Nv SHS
(QURE)
|
1.2 |
$20M |
|
850k |
23.93 |
|
Cullinan Oncology
(CGEM)
|
1.1 |
$20M |
|
1.9M |
10.35 |
|
Omeros Corp Note 9.500% 6/1 (Principal)
|
1.1 |
$19M |
|
6.5M |
2.97 |
|
Avalo Therapeutics Com New
(AVTX)
|
1.1 |
$19M |
|
1.1M |
18.16 |
|
Nurix Therapeutics
(NRIX)
|
1.0 |
$18M |
|
968k |
18.97 |
|
Taysha Gene Therapies Com Shs
(TSHA)
|
1.0 |
$18M |
|
3.3M |
5.50 |
|
Madrigal Pharmaceuticals
(MDGL)
|
1.0 |
$18M |
|
31k |
582.34 |
|
Savara
(SVRA)
|
1.0 |
$17M |
|
2.8M |
6.03 |
|
Protagonist Therapeutics
(PTGX)
|
0.9 |
$15M |
|
172k |
87.34 |
|
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
0.9 |
$15M |
|
601k |
25.01 |
|
Establishment Labs Holdings Ord
(ESTA)
|
0.8 |
$15M |
|
200k |
72.88 |
|
Erasca
(ERAS)
|
0.8 |
$15M |
|
3.9M |
3.72 |
|
Vera Therapeutics Cl A
(VERA)
|
0.7 |
$13M |
|
250k |
50.64 |
|
Cogent Biosciences
(COGT)
|
0.7 |
$12M |
|
350k |
35.52 |
|
Ovid Therapeutics
(OVID)
|
0.7 |
$12M |
|
7.2M |
1.63 |
|
Travere Therapeutics
(TVTX)
|
0.7 |
$12M |
|
300k |
38.21 |
|
Jade Biosciences Com New
(JBIO)
|
0.6 |
$11M |
|
715k |
15.43 |
|
Travere Therapeutics Note 2.250% 3/0 (Principal)
|
0.6 |
$10M |
|
7.0M |
1.43 |
|
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
0.5 |
$9.6M |
|
275k |
35.08 |
|
Celldex Therapeutics Com New
(CLDX)
|
0.5 |
$9.5M |
|
350k |
27.16 |
|
Zura Bio Class A Ord Shs
(ZURA)
|
0.5 |
$9.5M |
|
1.8M |
5.24 |
|
Tango Therapeutics
(TNGX)
|
0.5 |
$8.9M |
|
1.0M |
8.86 |
|
Sutro Biopharma Com Shs
(STRO)
|
0.5 |
$8.7M |
|
748k |
11.57 |
|
Revolution Medicines
(RVMD)
|
0.5 |
$8.0M |
|
100k |
79.65 |
|
Mbx Biosciences
(MBX)
|
0.4 |
$7.9M |
|
250k |
31.54 |
|
Miragen Therapeutics
(VRDN)
|
0.4 |
$7.8M |
|
250k |
31.12 |
|
Arcus Biosciences Incorporated
(RCUS)
|
0.4 |
$7.1M |
|
300k |
23.83 |
|
Sagimet Biosciences Com Ser A
(SGMT)
|
0.4 |
$6.8M |
|
1.1M |
5.92 |
|
Karyopharm Therapeutics Com New
(KPTI)
|
0.4 |
$6.5M |
|
890k |
7.36 |
|
Celcuity Note 2.750% 8/0 (Principal)
|
0.4 |
$6.5M |
|
3.0M |
2.17 |
|
Ascendis Pharma A/s Sponsored Adr
(ASND)
|
0.4 |
$6.4M |
|
30k |
213.24 |
|
Summit Therapeutics Put Option
(SMMT)
|
0.3 |
$6.1M |
|
350k |
17.49 |
|
Verrica Pharmaceuticals Com Shs
(VRCA)
|
0.3 |
$5.9M |
|
707k |
8.31 |
|
Engene Holdings
(ENGN)
|
0.3 |
$5.8M |
|
643k |
9.03 |
|
Newamsterdam Pharma Company *w Exp 99/99/999
(NAMSW)
|
0.3 |
$5.6M |
|
245k |
23.00 |
|
Rezolute Com New
(RZLT)
|
0.3 |
$5.5M |
|
2.4M |
2.36 |
|
Avadel Pharmaceuticals Com Shs
(AVDL)
|
0.3 |
$5.4M |
|
250k |
21.55 |
|
Eliem Therapeutics
(CLYM)
|
0.3 |
$5.2M |
|
1.3M |
4.00 |
|
Immunovant
(IMVT)
|
0.3 |
$5.1M |
|
200k |
25.42 |
|
Proqr Thrapeutics N V Shs Euro
(PRQR)
|
0.3 |
$5.0M |
|
2.5M |
2.02 |
|
Dianthus Therapeutics
(DNTH)
|
0.3 |
$4.7M |
|
115k |
41.21 |
|
Arrowhead Pharmaceuticals
(ARWR)
|
0.3 |
$4.6M |
|
70k |
66.39 |
|
Ibio Com New
(IBIO)
|
0.2 |
$4.0M |
|
2.1M |
1.93 |
|
Nextcure Com New
(NXTC)
|
0.2 |
$3.5M |
|
247k |
14.19 |
|
Crinetics Pharmaceuticals In
(CRNX)
|
0.2 |
$3.5M |
|
75k |
46.55 |
|
Belite Bio Sponsored Ads
(BLTE)
|
0.2 |
$3.2M |
|
20k |
159.96 |
|
Arrivent Biopharma
(AVBP)
|
0.2 |
$3.0M |
|
150k |
20.12 |
|
Mersana Therapeutics
(MRSN)
|
0.2 |
$2.9M |
|
100k |
28.93 |
|
Oaktree Acquisition Corp Iii Unit 10/04/2029
(OACCU)
|
0.2 |
$2.7M |
|
250k |
10.61 |
|
Arbutus Biopharma Call Option
(ABUS)
|
0.1 |
$2.5M |
|
522k |
4.81 |
|
Anteris Technologies Global
(AVR)
|
0.1 |
$2.4M |
|
487k |
4.99 |
|
Health Sciences Acq Corp 2
(OBIO)
|
0.1 |
$2.4M |
|
573k |
4.15 |
|
Eupraxia Pharmaceuticals
(EPRX)
|
0.1 |
$2.3M |
|
300k |
7.55 |
|
Geron Corporation
(GERN)
|
0.1 |
$2.0M |
|
1.5M |
1.32 |
|
Ultragenyx Pharmaceutical
(RARE)
|
0.1 |
$1.7M |
|
75k |
23.00 |
|
Lenz Therapeutics Put Option
(LENZ)
|
0.1 |
$1.6M |
|
100k |
16.00 |
|
Kezar Life Sciences Com New
(KZR)
|
0.1 |
$1.4M |
|
229k |
6.29 |
|
Compass Pathways Sponsored Ads
(CMPS)
|
0.1 |
$1.4M |
|
200k |
6.90 |
|
Cogent Biosciences Note 1.625%11/1 (Principal)
|
0.1 |
$1.2M |
|
1.0M |
1.18 |
|
Perspective Therapeutics Com New
(CATX)
|
0.0 |
$825k |
|
300k |
2.75 |
|
Macrogenics
(MGNX)
|
0.0 |
$780k |
|
484k |
1.61 |
|
Perceptive Cap Solutions Cor Cl A Ord Shs
(PCSC)
|
0.0 |
$652k |
|
50k |
13.03 |
|
X4 Pharmaceuticals Com New
(XFOR)
|
0.0 |
$580k |
|
145k |
4.00 |
|
Q32 Bio
(QTTB)
|
0.0 |
$92k |
|
28k |
3.32 |
|
Adagio Med Hldgs
(ADGM)
|
0.0 |
$83k |
|
80k |
1.04 |
|
Rocket Pharmaceuticals *w Exp 09/02/202
(RCKTW)
|
0.0 |
$1.8k |
|
75k |
0.02 |